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ABSTRACT
Dyskeratosis congenita (DC) is a premature ageing
syndrome characterised by short telomeres. An X-linked
form of DC is caused by mutations in DKC1 which
encodes dyskerin, a telomerase component that is
essential for telomerase RNA stability. However,
mutations in DKC1 are identiﬁable in only half of X-linked
DC families. A four generation family with pulmonary
ﬁbrosis and features of DC was identiﬁed. Affected
males showed the classic mucocutaneous features of DC
and died prematurely from pulmonary ﬁbrosis. Although
there were no coding sequence or splicing variants,
genome wide linkage analysis of 16 individuals across
four generations identiﬁed signiﬁcant linkage at the DKC1
locus, and was accompanied by reduced dyskerin protein
levels in affected males. Decreased dyskerin levels were
associated with compromised telomerase RNA levels
and very short telomeres. These data identify decreased
dyskerin levels as a novel mechanism of DC, and indicate
that intact dyskerin levels, in the absence of coding
mutations, are critical for telomerase RNA stability and
for in vivo telomere maintenance.
INTRODUCTION
Dyskeratosis congenita (DC) is a rare inherited
disorder deﬁned by a triad of mucocutaneous
features: skin hyperpigmentation, nail dystrophy,
and oral leukoplakia. In DC families, bone marrow
failure affects the majority of patients by the age
of 20, and is the primary cause of mortality in
70% of cases.
1 Pulmonary ﬁbrosis, liver cirrhosis,
and cancer account for the remaining causes.
1 DC is
a heritable, Mendelian disorder. Considering its
classic dermatologic diagnostic criteria, the X-linked
form of DC is most common, comprising half of all
cases.
2 Mutations in DKC1, which encodes the
dyskerin protein, underlie inheritance in 50% of
X-linked families,
34leaving the remaining cases
genetically uncharacterised. Whether the remaining
families have non-coding DKC1 mutations or
variants in other X-linked genes is not known.
Dyskerin is one of four proteins which form
a complex with RNAs that contain a box H/ACA
motif.
5 This class of non-coding RNAs includes the
RNA component of telomerase, hTR (also referred
to as TERC), and H/ACA small nucleolar RNAs
(snoRNAs).
56Missense mutations in DKC1 lead to
defects in hTR biogenesis and stability, and patients
with DKC1 mutations can have as little as 20% of
normal hTR levels.
78In addition to its role in hTR
stability, dyskerin uses H/ACA snoRNAs to guide
the site speciﬁc pseudouridylation of ribosomal
RNAs.
5This dual function of dyskerin has raised the
possibility that in addition to insufﬁcient hTR,
X-linked DC patients may have compromised
snoRNA levels and defects in ribosomal RNA
function.
9e11 However, in cells isolated from indi-
viduals with DKC1 missense mutations, decreased
snoRNA levels and pseudouridylation defects have
not been readily identiﬁed.
781 2Whether snoRNA
defects may be speciﬁc to a subset of missense
mutationsindyskerin,andnotothers,isnotknown.
DC falls on the severe end of a spectrum of
syndromes of telomere shortening.
13 Mutations in
the essential components of the enzyme telomerase,
hTERT, the telomerase reverse transcriptase, and
hTR, cause haploinsufﬁciency and autosomal domi-
nant DC.
14 15 In autosomal dominant DC due to
mutations in hTERTand hTR, the clinical phenotype
is heterogeneous and patients frequently present
with bone marrow failure, pulmonary ﬁbrosis or
liver disease in the absence of the classic mucocuta-
neous features.
15 16 In addition to DKC1, hTR, and
hTERT, mutations in the telomere binding protein
gene TINF2 account for a subset of young onset DC
cases.
17 18WeidentiﬁedanX-linkedDCpedigreethat
presented as familial pulmonary ﬁbrosis. Although
theDKC1sequencewasintact,genomewidelinkage
analysisimplicatedtheDKC1locus,andwedetected
signiﬁcantly decreased hTR and dyskerin protein
levels.Ourdatasuggestthatintactdyskerinlevels,in
the absence of coding mutations, are critical for hTR
stability and for telomere maintenance in X-linked
DC and pulmonary ﬁbrosis.
METHODS
Subjects
The family was identiﬁed as part of the Vanderbilt
Familial Pulmonary Fibrosis Registry based on the
conﬁrmed diagnosis of idiopathic interstitial lung
disease in two or more members.
19 The study was
approved by the local institutional review boards of
Johns Hopkins and Vanderbilt Universities. Written
informed consent was obtained from all subjects.
Conﬁrmation of the pulmonary ﬁbrosis diagnosis
was based on clinical assessment of the proband
and review of the medical history and records of
related individuals. The average length of telomeres
was measured in primary lymphocytes by ﬂow
cytometry and ﬂuorescence in situ hybridisation
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Telomere biology(FISH) (Repeat Diagnostics, North Vancouver, BC, Canada), as
described.
19 Lymphoblastoid cell lines were generated from
peripheral blood lymphocytes as described.
20 Control lympho-
blastoid cells were derived from healthy male donors or from an
unaffected male relative.
X-inactivation and FISH analysis
We performed X-inactivation analysis using the HUMARA-PCR
assay.
21 Brieﬂy, genomic DNA was digested with a methylation
speciﬁc enzyme (HpaII). PCR was performed at the polymorphic
androgen receptor locus which contains (CAG)n repeats. After
PCR ampliﬁcation, we determined allele size on an ABI Genome
Analyzer, and measured the ratio of methylated to unmethylated
alleles. We performed metaphase FISH analysis using a probe
mixture containing the Xq subtelomere (ToTelVysion Subtelo-
meric probe set, Vysis/Abbott Molecular, Des Plaines, Il, USA).
Sequencing
The 15 DKC1 exons, 39UTR and promoter regions were ampliﬁed
and sequenced using the listed primers (supplementary tables 1
and 2). Sequences were manually inspected (Sequencher v.4.9,
Gene Codes, Ann Arbor, MI, USA), and variants were compared
with entries in dbSNP build 130 (http://www.ncbi.nlm.nih.gov/
projects/SNP/). Human Genome Build 36.3 (hg18) was used. The
cDNA library was generated from total RNA isolated from
transformed lymphoblastoid cells (RNeasy, Qiagen, Valencia,
CA, USA; and Superscript III First-Strand Synthesis System,
Invitrogen, Carlsbad, CA, USA). Ampliﬁcation and sequencing of
the DKC1 mRNA was performed as described.
4
Linkage analysis
Genomic DNA was genotyped using the Inﬁnium II Human
linkage 12 panel (Illumina, San Diego, CA, USA). Single nucleo-
tide polymorphisms (SNPs) used in the analysis had >99% call
rates. The DeCode genetic map was used to describe SNP posi-
tion. No SNPs were found to be out of HardyeWeinberg equi-
librium, and we used Pedcheck to conﬁrm pedigree relationships
and check for Mendelian inconsistencies.
22 Linkage disequilib-
rium (LD) blocks (D’¼0.7) were identiﬁed using Haploview,
23
and tagging SNPs from each haplotype block were selected for
subsequent linkage analysis to ensure the SNPs were not corre-
lated. Linkage analysis was performed using MINX software
using a parametric X-linked recessive model (prevalence of 0.0001
and penetrance of0.0001,0.05, 0.99for females andpenetrance of
0.0001, 0.99 for males).
24
Western blot
Total protein was isolated from early passage lymphoblastoid
cell pellets (passage 1e5) which were lysed in radio-
immunoprecipitation assay (RIPA) buffer for 15 min on ice in
the presence of protease inhibitors (Mini Complete, Roche,
Indianapolis, IN, USA). Samples were centrifuged at maximum
speed for 10 min, and total cellular protein quantitated using
Bicinchoninic Acid assay (Pierce, Rockford, IL, USA). Proteins
were separated using SDS-gel electrophoresis and transferred to
polyvinylidene ﬂuoride (PVDF) membrane under reducing
conditions (Invitrogen). Primary antibodies for dyskerin and
actin were obtained from Santa Cruz (sc-48794, lot D0809,
Santa Cruz, CA, USA) and AbCam (ab8226, Cambridge, MA,
USA), respectively. Detection was performed using near-infrared
ﬂuorescent conjugated secondary antibodies (LI-COR, Lincoln,
NE, USA). We visualised the two proteins simultaneously on
a single membrane without stripping using the two channel
near infrared Odyssey scanner (LI-COR). We measured dyskerin
protein levels by normalising dyskerin intensity to the intensity
of the b-actin loading control using Odyssey software.
Quantitative reverse transcription PCR
Total RNA was isolated from early passage lymphoblastoid cells
and reverse transcribed using Superscript III and random
hexamers according to the manufacturer’s protocol (Invitrogen).
Quantitative reverse transcription PCR (qRT-PCR) was
performed using Syber-Green Supermix with 200 nM ﬁnal
primer concentrations and 5e10 ng of cDNA. All products were
cloned (TOPO TA cloning kit, Invitrogen) and sequence veriﬁed.
Studies were performed in triplicate, and each experiment was
performed at least twice. The expression in each sample was
normalised to ARF3 levels.
25 hTR was quantiﬁed by qRT-PCR.
25
We quantiﬁed U23 and U3 levels as described.
26 U64 forward
and reverse primers were as follows: 59-CTCGGCTCTGCA-
TAGTTGC-39 and 59-CAAGGAAAGAGAGGCCACAG-39. DKC1
expression was quantiﬁed using two primer sets. Primer set 1
spanned exons 11 and 12: 59-CCCCGCTCTCCAGACCAGCT-39
and 59-AAGCCCCGCAGGTAGTTGCC-39. Primer set 2 spanned
exons 13 and 14: 59-CTGCTATGGGGCCAAGATTA-39 and
59-CCATGGTCGCAGGTAGAGAT-39.
RESULTS
DC presents as familial pulmonary ﬁbrosis
In patients with classic DC, 20% of patients have a diagnosis of
pulmonary disease.
1 To determine whether DC cases can be
occult in a familial pulmonary ﬁbrosis registry, we queried 75
consecutive probands for a history of oral leukoplakia, nail
dystrophy or skin hyperpigmentation. We identiﬁed one proband
who had classic DC features. The proband presented with
shortness of breath at the age of 49 years and, at the time, had
mild nail dystrophy and skin hyperpigmentation. Family history
revealed a cousin who died from pulmonary ﬁbrosis at the age of
39. This relative also had nail dystrophy, skin hyperpigmenta-
tion, and liver cirrhosis. These observations indicated that
DC can manifest as familial pulmonary ﬁbrosis, albeit rarely.
To determine the genetic basis of the DC phenotype in this
family (designated #58), we screened genomic DNA from the
proband for mutations in hTR and hTERT, the known genes that
cause both familial pulmonary ﬁbrosis and DC,
19 27 but did not
identify a mutation. The sequence for TINF2 was also intact. To
probe the genetic basis further, we obtained a comprehensive
ﬁve generation history. The family reported Irish ancestry, and
the pedigree revealed premature mortality in males and three
generations of individuals who had the typical mucocutaneous
features of DC (ﬁgure 1, supplementary table 3). In total, the
family history revealed eight males who died prematurely at
a mean age of 37 years (range 17e51 years). Three died from
complications of pulmonary disease alone, and three had both
lung disease and liver cirrhosis. Another male died from meta-
static squamous cell carcinoma at the age of 34 years (supple-
mentary table 3). The family history did not reveal any cases of
aplastic anaemia, myelodysplastic syndrome, or acute myeloid
leukaemia. The pedigree suggested that this kindred may display
X-linked recessive inheritance.
DC predominately affects males even in autosomal dominant
families.
28 To conﬁrm the pattern of inheritance, we examined
X-inactivation patterns using the HUMARA PCR based assay.
21
We found skewed X-inactivation in genomic DNA from
peripheral blood in two females (90% and 100% respectively,
ﬁgure 2A). The skewing was also present in DNA extracted from
saliva, consistent with a germline defect on the X-chromosome
(ﬁgure 2B). Since females in X-linked DC have been previously
328 J Med Genet 2011;48:327e333. doi:10.1136/jmg.2010.085100
Telomere biologydescribed to have skewed X-inactivation,
29 30 these data
conﬁrmed that the mutant gene in this family was on the
X-chromosome.
Dyskerin sequence is unaltered in family 58
The DKC1 gene is mutated in X-linked DC
3; we therefore
sequenced its 15 coding exons in the proband but did not
identify variants. Since the disease gene was presumed haploid
on the X-chromosome, this analysis also indicated that the
proband did not carry a deletion in DKC1. To exclude a mutation
that altered splicing, we generated lymphoblastoid lines from an
affected male and ampliﬁed the DKC1 cDNA. We identiﬁed no
evidence of aberrant splicing or exon duplication. Therefore, the
mutation that underlies inheritance in this X-linked DC family
was not in the coding sequence and did not affect DKC1
splicing.
Figure 2 Skewed X-inactivation in
family 58 females and very short
telomeres in affected individuals. (A) X-
inactivation analysis of the androgen
receptor locus in blood genomic DNA
shows skewing in two females (IV.8 and
IV.10, ﬁgure 1) compared to unrelated
female controls. As expected, only
a single allele is detected in genomic
DNA from a male. Allele frequencies are
compared with and without digestion
with methylation speciﬁc restriction
enzyme (HpaII) before PCR
ampliﬁcation. (B) X-inactivation analysis
of genomic DNA from saliva from the
same females also shows skewed
ratios. (C) Lymphocyte telomere length
of affected individuals are plotted by age
relative to per cent normogram of
healthy controls (n¼400). Affected
males have very short telomeres, at or
less than the 1st centile, compared with
age matched individuals. Carrier females
also have telomere length near the 10th
centile. Identiﬁers refer to pedigree
position in ﬁgure 1. Males with known
missense mutation Q31E also have very
short telomeres by ﬂow ﬂuorescence in
situ hybridisation (FISH).
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Figure 1 Pulmonary ﬁbrosis pedigree
with dyskeratosis congenita (DC)
features. The proband is indicated by an
arrow, and * indicates subjects from
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had classic features of DC or very short
telomeres (<1st centile). Females were
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affected male offspring or had skewed
inactivation of the X-chromosome.
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Telomere biologyAffected individuals have short telomeres
To conﬁrm whether the clinical syndrome in this X-linked DC
family is telomere mediated, we measured the telomere length.
Lymphocyte telomere length identiﬁes patients with germline
defects due to telomerase dysfunction.
19 31 32 In four affected
males, the telomere length was at or below the 1st centile
compared to healthy age matched controls (p¼0.009, paired
t test, ﬁgure 2C). This range, which is three standard deviations
below the mean, is diagnostic of an inherited mutation that
affects telomerase or telomere maintenance. In a healthy male
sibling, the telomere length was greater than the 50th centile
(ﬁgure 2C). These data suggested that the inherited defect in this
DC family affects telomere maintenance.
Genome wide linkage identiﬁes the DKC1 locus
The absence of a readily identiﬁable mutation in the DKC1
gene and the presence of short telomeres suggested two main
possibilities: either another gene on the X-chromosome which
affects telomere maintenance underlies the inheritance in this
family, or the DC features in this family can be attributed to
a novel mechanism which affects dyskerin function. To begin to
distinguish these, we performed linkage analysis on the X chro-
mosome using SNP data from 16 individuals. Using an X-linked
recessive model, we identiﬁed a single 47 cM peak on Xq28 with
a maximum log of the odds ratio (LOD) score of 3.25 (ﬁgure 3,
supplementarytable4).TheremainderoftheXchromosomewas
notinvolvedastheLODscorewaslessthan 2.Thislinkagepeak
ﬂanked and contained the genomic locus for dyskerin (ﬁgure 3).
We examined bioinformatically the 134 protein coding genes
that fell within the linkage peak and found that only DKC1 had
been previously implicated in telomere maintenance. However,
several genes of unknown function were also present under the
linkage peak. A list of the protein coding genes is listed in
supplementary table 5. Therefore, although the DKC1 sequence
was intact, an inherited mutation affecting the DKC1 locus was
responsible for the inheritance of the disease phenotype.
Affected individuals have reduced telomerase RNA levels
Dyskerin is a box H/ACA protein and is essential for hTR
stability and biogenesis.
5 7 In patients with point mutations in
DKC1, low hTR levels cause telomere shortening and telomere
mediated disease.
7 Since our linkage study suggested that
a mutation that affects DKC1 may underlie the inheritance in
this DC family, we tested whether affected individuals have low
hTR levels. We quantiﬁed hTR in cells from affected males and
compared them to healthy controls using quantitative real time
PCR. We found hTR levels were 25% of control levels (p¼0.043,
Student t test, ﬁgure 4A). hTR levels were also decreased in cells
from DC patients who carried a known missense dyskerin
mutation (Q31E), as previously shown.
8 We examined but did
not detect a difference in U23 and U64, two H/ACA snoRNAs.
There was also no signiﬁcant difference in the levels of U3,
a member of the box C/D snoRNA family (ﬁgure 4B).
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Figure 4 Telomerase RNA and
dyskerin protein levels are
compromised in affected males. (A)
Quantitative reverse transcription PCR
(qRT-PCR) of hTR shows decreased
levels in affected males compared with
controls. hTR levels are also decreased
in cells with a dyskerin Q31E missense
mutation, as was previously shown. (B)
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change between affected individuals
and controls. qRT-PCR data were
normalised relative to ARF3 levels. (C)
Representative grey scale Western blot
image of one of the near-infrared colour
ﬂuorescent images used for
quantitation. Molecular weight standard
is shown on the left (kDa). Dyskerin
appears at the expected size of 58 kDa
in affected individuals designated with
‘A’ and controls designated ‘C,’ as well
as Hela cells. Lane 10 contains protein
extract from a healthy male from family
58 who has long telomeres (pedigree ID V.3, ﬁgure 1). A total of 10 mg of protein was loaded in each lane. (D) Quantitation of near-infrared
ﬂuorescence intensity from ﬁve independent experiments including the gel shown in (C) shows decreased dyskerin levels in affected males compared
with controls. Each experiment contained control cells (n¼5e7), affected individuals (n¼3e4), and Q31E mutation carriers (n¼2). Studies shown here
used RNA and protein extracted from early passage lymphoblastoid lines (passage 1e5). Means were compared using the Student t test. Error bars
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Telomere biologyThese data suggested that the primary defect in this family
causes telomere shortening, by decreasing hTR stability.
Dyskerin protein levels are decreased
Since the linkage analysis along with decreased hTR levels
suggested that the DKC1 gene locus contained the culprit defect,
we tested whether a decrease in dyskerin protein levels may
underlie the telomere shortening in this pedigree. We measured
dyskerin levels by Western blot using a sensitive near-infrared
ﬂuorescence detection method.
33 Total protein extracted from
lymphoblastoid cells from clinically affected members contained
the expected 58 kDa product identical to Hela cells and controls
(representative image, ﬁgure 4C). However, in males who had
short telomeres, dyskerin protein levels were signiﬁcantly
decreased relative to actin. In ﬁve independent experiments, we
detected a decrease in dyskerin levels with a mean 67% of
controls (range 52e72%, p<0.0001, Student t test, ﬁgure 4D).
The dyskerin protein levels in males were also lower compared
to a healthy related male with long telomeres (ﬁgure 4C). Our
data indicated that decreased dyskerin protein levels contributed
to the telomere shortening in this family.
Examining DKC1 transcriptional regulatory elements
The decreaseindyskerin proteinlevelsinthepresenceofanintact
coding and cDNA sequence raised the possibility that a mutation
that might affect proximal DKC1 regulatory elements underlies
the genetic defect. However, quantitation of DKC1 expression
using two independent primer sets was intact (supplementary
ﬁgure 1). Nonetheless, to test this possibility, we ampliﬁed the 59
upstream sequences which include the promoter (0.8 kb), as well
as the 39 UTR (0.8 kb), but found no variants. To determine
whether regulatory elements may be located near dyskerin, we
aligned mammalian DKC1 sequences. Based on conservation
algorithms available (phastCons, http://genome.ucsc.edu), we
found no conserved elements in non-coding regions, and predic-
tion programs did not identify putative enhancers or transcrip-
tion factor binding sites (Vista Enhancers and Yale TFBS, http://
genome.ucsc.edu, supplementary ﬁgure 2). Insulator prediction
programs predicted an insulator element within intron 1 (http://
insulatordb.uthsc.edu/), but sequencing of both introns 1 and 2
did notreveal variants from reference. The sequences of snoRNAs
(SNORA36a and SNORA56) within introns 8 and 12 were also
intact. To determine if more remote elements were involved, we
ampliﬁed and sequenced the 11.6 kb upstream and 1 kb down-
stream intergenic sequences (supplementary ﬁgure 2), but found
no deviations from reference sequence with the exception of
a G to A transition, 7.8 kb upstream of dyskerin, within a long
interspersed nuclear element (LINE). This is the only sequence
variant we identiﬁed in the proband near the DKC1 gene. We also
considered the possibility that a balanced translocation that
disrupted the regulatory element may underlie the phenotype
in this family, but metaphase FISH with X-chromosome speciﬁc
probes did not reveal a micro-translocation. These data suggested
that a micro-translocation larger than the resolution of meta-
phase FISH probes (1e3 Mb) is not likely.
34 Altogether, the intact
expressionofDKC1,along withtheabsence ofreadily identiﬁable
variants in known regulatory elements, suggested that a poten-
tially novel mechanism that controls dyskerin protein levels is
defective in this family.
Carrier females have short telomeres and mild DC features
We next examined the clinical phenotypes in carrier females
where attenuated disease features are known to occur in
X-linked disorders.
35 We identiﬁed nail ridging characteristic of
DC in one of four female carriers examined (ﬁgure 5A). Female
carriers also had telomere lengths that were shorter than the
Figure 5 Clinical features of affected
members. (A) Dystrophic nail changes
with typical ridging of dyskeratosis
congenita (DC) are shown in this
photomicrograph of a female carrier. The
telomere length for this individual is
shown in ﬁgure 2C. (B) Nail dystrophy in
an affected male child with very short
telomeres in ﬁgure 2C. (C) Lung biopsy
from the proband shows changes of
bronchiolitis obliterans organising
pneumonia and usual interstitial
pneumonia patterns typical of idiopathic
pulmonary ﬁbrosis. (D) Biopsy from
another affected individual (III.10) shows
late stage idiopathic pulmonary ﬁbrosis
changes of bronchiolitis obliterans
organising pneumonia and usual
interstitial pneumonia. Subject gave
informed consent for this study which
included permission to publish clinical
images.
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Telomere biology50th centile of controls (n¼4, p¼0.022, paired t test, ﬁgure 2C).
Since telomere length is inherited,
36 these data suggested that
telomere shortening may contribute to the low penetrance
dyskeratosis phenotype in some carrier females.
Prominent pulmonary and liver phenotypes in DC kindred
To determine the spectrum of telomere mediated disease associ-
ated with decreased dyskerin levels, we carefully examined the
clinical phenotype. In several young males, nail dystrophy was
the ﬁrst manifestation and was evident bythe age of 15 (ﬁgure 5B
and supplementary table 3). In the two cases where pulmonary
ﬁbrosiswasbiopsyproven,therewasevidenceofusualinterstitial
pneumonia as well as bronchiolitis obliterans organising pneu-
monia, a histologic manifestation which sometimes accompanies
idiopathic pulmonary ﬁbrosis (ﬁgure 5C,D). Both patients had
honeycomb changes radiographically, did not respond to steroids,
and died from their lung disease. These cases conﬁrm prior
observations suggesting that other interstitial lung disease
histopathologies may co-exist in the same individual or within
the same family along with usual interstitial pneumonia, and are
manifestations of the same underlying genetic process.
19 37
Although aplastic anaemia and cytopenias occur in >85% of
patients with classic features ofDC,
13 8a detailed medical records
review from 12 affected individuals did not reveal evidence of
bone marrow failure. The data suggested that patients with
classic DC can have their most prominent complications in the
lung, and that these manifestations are sufﬁcient to cause life
threatening disease in the absence of bone marrow failure.
DISCUSSION
In this study, we identify decreased dyskerin protein levels as
a novel mechanism of disease in X-linked DC. In affected indi-
viduals, despite the presence of an intact coding sequence,
decreased dyskerin levels were associated with reduced hTR
stability and telomere shortening. Knockdown of dyskerin levels
has been previously shown to decrease hTR levels in cancer cell
lines,
39 40 although its consequences on telomere length have not
been examined. Our data indicate that intact dyskerin levels,
and not only protein sequence, are essential for in vivo telomere
maintenance, and this defect is sufﬁcient to cause premature
mortality due to telomere mediated disease. In half of X-linked
DC families, the mechanism of disease is not known. Our data,
if replicated in larger cohorts, would suggest that quantitation
of dyskerin protein levels can complement sequencing of the
DKC1 gene, and decreased levels of dyskerin, measured by
sensitive methods, can identify male carrier status in a subset of
genetically uncharacterised families.
Our family study highlights the high penetrance of pulmonary
disease in patients with classic features of DC. Traditionally, DC
has been associated with premature mortality from bone marrow
failure.
41 42 Recent studies showing that mutations in hTERTand
hTR have their most common manifestations in the lung
(reviewed by Armanios
13), along with the ﬁndings in this study,
suggest that the penetrance of pulmonary phenotypes in families
with DC may have been underestimated. In a DC registry where
probands were recruited based on the classic mucocutaneous
features, 20% of patients had pulmonary disease.
1 Our study
indicates that, in the absence bone marrow failure, pulmonary
and liver disease can be primary causes of mortality in some DC
families. Similar to autosomal dominant families with mutations
in hTERT or hTR, the median age of death due to pulmonary
disease was older (39 years), nearly two decades later than bone
marrow failure onset in DC registries.
19 41 These observations
underscore the heterogeneity of DC phenotypes, and the fact
that pulmonary disease may represent an attenuated, adult onset
telomere phenotype which manifests rarely in individuals
younger than the age of 20 years. These patterns have important
clinical implications as DC patients should be rigorously coun-
selled against tobacco exposure, and iatrogenic pulmonary toxins
should be avoided because of the known high rate of complica-
tions.
43 Although in our study female carriers were clinically
unaffected except for the presence of nail dystrophy, it is possible
the short telomeres they carry may be associated with an
increased risk of developing telomere mediated disease, especially
later in life. Future studies are needed in this area.
Howdoweexplaintheobservationthat,inthisfamily,affected
males had decreased dyskerin protein and hTR levels, yet no
change in DKC1 mRNA levels? Several possibilities may account
for this. MicroRNAs (miRNAs) are post-transcriptional regula-
tors of protein levels.
44 It is theoretically possible that this family
harbours a gain-of-function miRNA mutation that accounts for
this observation. Disease causing germline mutations in miRNAs
have been hypothesised, but to our knowledge, have not yet been
showntocauseMendeliandisease.
45Inthelinkagepeak,thereare
32 predicted miRNAs genes (listed in supplementary table 5)
which are potential candidates. Regulatory RNAs known as large
intergenic non-coding RNAs (lincRNAs) have also been recently
shown to regulate protein levels directly, and it is possible that
a mutation that affects these genes would alter dyskerin levels.
46
No lincRNAs have been heretofore identiﬁed within our linkage
peak. Another alternative explanation is that a loss-of-function
mutation in a protein coding gene that has a yet-to-be identiﬁed
function in telomere biology underlies the decreased dyskerin
levels. Several biochemical studies have examined the dyskerin
interacting proteins,
47e49 but none of them are identiﬁable as one
oftheproteingenesthat fallunderthelinkage peakin thisfamily.
Examining these possibilities in future studies could lead to
important insights into the relevant genetic determinants of
telomere length and age related disease in humans.
Although we identiﬁed signiﬁcant decreases in hTR associated
with lower dyskerin levels, we did not identify a compromise in
the H/ACA snoRNA levels we examined. Our data are similar to
prior studies which did not identify decreases in snoRNA levels
in cells from patients with DKC1 missense mutations.
7 8 These
data differ from those in mouse cells where DKC1 mutations
were associated with a decrease in snoRNA levels.
9e11 The
contrast between human and mouse studies suggests that in
human cells, hTR levels may be more sensitive to dyskerin dose
ﬂuctuation than snoRNAs.
In summary, intact dyskerin levels are critical for hTR
stability and in vivo telomere maintenance. A decrease in
dyskerin protein, in the absence of coding mutations, is associ-
ated with a spectrum of telomere mediated disease which clin-
ically manifests as familial pulmonary ﬁbrosis and DC. If
replicated in other families, careful quantitation of dyskerin
protein levels may be useful for identifying male carrier status in
uncharacterised X-linked DC families.
Acknowledgements We are grateful to all the family members who participated
in this study. This work was supported by funding from the National Institutes of
Health (K08CA118416) and the Doris Duke Charitable Foundation (to MA). EMP
received support from an NHLBI supplement to Medical Scientist Training Program
Award T32GM007309.
Funding Other Funders: NIH; Doris Duke Foundation.
Patient consent Obtained.
Ethics approval Approval was provided from both the Johns Hopkins and Vanderbilt
University School of Medicine’s Institutional Review Boards.
Provenance and peer review Not commissioned; externally peer reviewed.
332 J Med Genet 2011;48:327e333. doi:10.1136/jmg.2010.085100
Telomere biologyREFERENCES
1. Kirwan M, Dokal I. Dyskeratosis congenita: a genetic disorder of many faces.
Clin Genet 2008;73:103e12.
2. Savage SA, Dokal I, Armanios M, Aubert G, Cowen EW, Domingo DL, Giri N, Greene
MH, Orchard PJ, Tolar J, Tsilou E, Van Waes C, Wong JM, Young NS, Alter BP.
Dyskeratosis congenita: the ﬁrst NIH clinical research workshop. Pediatr Blood
Cancer 2009;53:520e3.
3. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A,
Dokal I. X-linked dyskeratosis congenita is caused by mutations in a highly conserved
gene with putative nucleolar functions. Nat Genet 1998;19:32e8.
4. Knight SW, Vulliamy TJ, Morgan B, Devriendt K, Mason PJ, Dokal I. Identiﬁcation of
novel DKC1 mutations in patients with dyskeratosis congenita: implications for
pathophysiology and diagnosis. Hum Genet 2001;108:299e303.
5. Meier UT. The many facets of H/ACA ribonucleoproteins. Chromosoma
2005;114:1e14.
6. Mitchell JR, Cheng J, Collins K. A box H/ACA small nucleolar RNA-like domain at
the human telomerase RNA 39 end. Mol Cell Biol 1999;19:567e76.
7. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human
disease dyskeratosis congenita. Nature 1999;402:551e5.
8. Wong JM, Kyasa MJ, Hutchins L, Collins K. Telomerase RNA deﬁciency in
peripheral blood mononuclear cells in X-linked dyskeratosis congenita. Hum Genet
2004;115:448e55.
9. Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, Rao PH, Cordon-Cardo C, Pandolﬁ
PP. Dyskeratosis congenita and cancer in mice deﬁcient in ribosomal RNA
modiﬁcation. Science 2003;299:259e62.
10. Ge J, Crosby SD, Heinz ME, Bessler M, Mason PJ. SnoRNA microarray analysis
reveals changes in H/ACA and C/D RNA levels caused by dyskerin ablation in mouse
liver. Biochem J 2010;429:33e41.
11. Ge J, Rudnick DA, He J, Crimmins DL, Ladenson JH, Bessler M, Mason PJ. Dyskerin
ablation in mouse liver inhibits rRNA processing and cell division. Mol Cell Biol
30:413e22.
12. Wong JM, Collins K. Telomerase RNA level limits telomere maintenance in X-linked
dyskeratosis congenita. Genes Dev 2006;20:2848e58.
13. Armanios M. Syndromes of telomere shortening. Annu Rev Genomics Hum Genet
2009;10:45e61.
14. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I. The
RNA component of telomerase is mutated in autosomal dominant dyskeratosis
congenita. Nature 2001;413:432e5.
15. Armanios M, Chen JL, Chang YP, Brodsky RA, Hawkins A, Grifﬁn CA, Eshleman JR,
Cohen AR, Chakravarti A, Hamosh A, Greider CW. Haploinsufﬁciency of telomerase
reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis
congenita. Proc Natl Acad Sci U S A 2005;102:15960e4.
16. Fogarty PF, Yamaguchi H, Wiestner A, Baerlocher GM, Sloand E, Zeng WS, Read
EJ, Lansdorp PM, Young NS. Late presentation of dyskeratosis congenita as
apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet
2003;362:1628e30.
17. Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP. TINF2,
a component of the shelterin telomere protection complex, is mutated in dyskeratosis
congenita. Am J Hum Genet 2008;82:501e9.
18. Walne AJ, Vulliamy T, Beswick R, Kirwan M, Dokal I. TINF2 mutations result
in very short telomeres: analysis of a large cohort of patients with
dyskeratosis congenita and related bone marrow failure syndromes. Blood
2008;112:3594e600.
19. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, Lawson WE,
Xie M, Vulto I, Phillips JA 3rd, Lansdorp PM, Greider CW, Loyd JE. Telomerase
mutations in families with idiopathic pulmonary ﬁbrosis. N Engl J Med
2007;356:1317e26.
20. Penno MB, Pedrotti-Krueger M, Ray T. Cryopreservation of whole blood and
isolated lymphocytes for B-cell transformation. J Tissue Cult Methods
1993;15:43e8.
21. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation
of HpaII and HhaI sites near the polymorphic CAG repeat in the human
androgen-receptor gene correlates with X-chromosome inactivation. Am J Hum
Genet 1992;51:1229e39.
22. Wigginton JE, Abecasis GR. PEDSTATS: descriptive statistics, graphics and quality
assessment for gene mapping data. Bioinformatics 2005;21:3445e7.
23. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and
haplotype maps. Bioinformatics 2005;21:263e5.
24. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlinerapid analysis of dense
genetic maps using sparse gene ﬂow trees. Nat Genet 2002;30:97e101.
25. Cristofari G, Lingner J. Telomere length homeostasis requires that telomerase levels
are limiting. EMBO J 2006;25:565e74.
26. Romanova L, Kellner S, Katoku-Kikyo N, Kikyo N. Novel role of nucleostemin in the
maintenance of nucleolar architecture and integrity of small nucleolar
ribonucleoproteins and the telomerase complex. J Biol Chem 2009;284:26685e94.
27. Tsakiri KD, Cronkhite JT, Kuan PJ, Xing C, Raghu G, Weissler JC, Rosenblatt RL,
Shay JW, Garcia CK. Adult-onset pulmonary ﬁbrosis caused by mutations in
telomerase. Proc Natl Acad Sci U S A 2007;104:7552e7.
28. Basel-Vanagaite L, Dokal I, Tamary H, Avigdor A, Garty BZ, Volkov A, Vulliamy T.
Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita
caused by TERT mutations. Haematologica 2008;93:943e4.
29. Devriendt K, Matthijs G, Legius E, Schollen E, Blockmans D, van Geet C, Degreef H,
Cassiman JJ, Fryns JP. Skewed X-chromosome inactivation in female carriers of
dyskeratosis congenita. Am J Hum Genet 1997;60:581e7.
30. Vulliamy TJ, Knight SW, Dokal I, Mason PJ. Skewed X-inactivation in carriers of
X-linked dyskeratosis congenita. Blood 1997;90:2213e16.
31. AlterBP,BaerlocherGM,SavageSA,Chanock SJ,WekslerBB,WillnerJP,PetersJA,
Giri N, Lansdorp PM. Very short telomere length by ﬂow ﬂuorescence in situ
hybridizationidentiﬁespatientswithdyskeratosiscongenita.Blood2007;110:1439e47.
32. Alder JK, ChenJJ, Lancaster L,Danoff S,Su SC, Cogan JD,Vulto I, Xie M, Qi X, Tuder
RM, Phillips JA 3rd, Lansdorp PM, Loyd JE, Armanios MY. Short telomeres are a risk
factor for idiopathic pulmonary ﬁbrosis. Proc Natl Acad Sci U S A 2008;105:13051e6.
33. Mathews ST, Plaisance EP, Kim T. Imaging systems for westerns:
chemiluminescence vs. infrared detection. Methods Mol Biol 2009;536:499e513.
34. Menten B, Maas N, Thienpont B, Buysse K, Vandesompele J, Melotte C, de Ravel T,
Van Vooren S, Balikova I, Backx L, Janssens S, De Paepe A, De Moor B, Moreau Y,
Marynen P, Fryns JP, Mortier G, Devriendt K, Speleman F, Vermeesch JR. Emerging
patterns of cryptic chromosomal imbalance in patients with idiopathic mental
retardation and multiple congenital anomalies: a new series of 140 patients and
review of published reports. J Med Genet 2006;43:625e33.
35. Migeon BR. The role of X inactivation and cellular mosaicism in women’s health and
sex-speciﬁc diseases. JAMA 2006;295:1428e33.
36. Armanios M, Alder JK, Parry EM, Karim B, Strong MA, Greider CW. Short telomeres
are sufﬁcient to cause the degenerative defects associated with aging. Am J Hum
Genet 2009;85:823e32.
37. Cronkhite JT, Xing C, Raghu G, Chin KM, Torres F, Rosenblatt RL, Garcia CK.
Telomere shortening in familial and sporadic pulmonary ﬁbrosis. Am J Respir Crit Care
Med 2008;178:729e37.
38. Knight S, Vulliamy T, Copplestone A, Gluckman E, Mason P, Dokal I. Dyskeratosis
Congenita (DC) Registry: identiﬁcation of new features of DC. Br J Haematol
1998;103:990e6.
39. Montanaro L, Brigotti M, Clohessy J, Barbieri S, Ceccarelli C, Santini D, Taffurelli M,
Calienni M, Teruya-Feldstein J, Trere D, Pandolﬁ PP, Derenzini M. Dyskerin expression
inﬂuences the level of ribosomal RNA pseudo-uridylation and telomerase RNA
component in human breast cancer. J Pathol 2006;210:10e18.
40. Montanaro L, Calienni M, Ceccarelli C, Santini D, Taffurelli M, Pileri S, Trere D,
Derenzini M. Relationship between dyskerin expression and telomerase activity in
human breast cancer. Cell Oncol 2008;30:483e90.
41. Savage SA, Alter BP. Dyskeratosis congenita. Hematol Oncol Clin North Am
2009;23:215e31.
42. Dokal I, Vulliamy T. Dyskeratosis congenita: its link to telomerase and aplastic
anaemia. Blood Rev 2003;17:217e25.
43. Yabe M, Yabe H, Hattori K, Morimoto T, Hinohara T, Takakura I, Shimizu T,
Shimamura K, Tang X, Kato S. Fatal interstitial pulmonary disease in a patient with
dyskeratosis congenita after allogeneic bone marrow transplantation. Bone Marrow
Transplant 1997;19:389e92.
44. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis,
function and decay. Nat Rev Genet 2010;11:597e610.
45. Chang TC, Mendell JT. microRNAs in vertebrate physiology and human disease.
Annu Rev Genomics Hum Genet 2007;8:215e39.
46. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O,
Carey BW, Cassady JP, Cabili MN, Jaenisch R, Mikkelsen TS, Jacks T, Hacohen N,
Bernstein BE, Kellis M, Regev A, Rinn JL, Lander ES. Chromatin signature reveals
over a thousand highly conserved large non-coding RNAs in mammals. Nature
2009;458:223e7.
47. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR. Protein
composition of catalytically active human telomerase from immortal cells. Science
2007;315:1850e3.
48. Venteicher AS, Abreu EB, Meng Z, McCann KE, Terns RM, Veenstra TD, Terns MP,
Artandi SE. A human telomerase holoenzyme protein required for Cajal body
localization and telomere synthesis. Science 2009;323:644e8.
49. Venteicher AS, Meng Z, Mason PJ, Veenstra TD, Artandi SE. Identiﬁcation of
ATPases pontin and reptin as telomerase components essential for holoenzyme
assembly. Cell 2008;132:945e57.
J Med Genet 2011;48:327e333. doi:10.1136/jmg.2010.085100 333
Telomere biology